Search Results Search Sort by RelevanceMost Recent Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940. Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933. Case and Commentary Nov 2008 Ethics of Expedited Partner Therapy, Commentary 1 Matthew R. Golden, MD, MPH and Matthew Hogben, PhD Using expedited partner therapy to treat certain STDs entails clinical and ethical risks and benefits. Virtual Mentor. 2008;10(11):708-715. doi: 10.1001/virtualmentor.2008.10.11.ccas3-0811. Case and Commentary Nov 2008 Ethics of Expedited Partner Therapy, Commentary 2 Mark A. Levine, MD Using expedited partner therapy to treat certain STDs entails clinical and ethical risks and benefits. Virtual Mentor. 2008;10(11):708-718. doi: 10.1001/virtualmentor.2008.10.11.ccas3-0811. Policy Forum Oct 2005 From Research to Policy: Expedited Partner Therapy for Chlamydia Jeffrey D. Klausner, MD, MPH Research is critical to the development of public policy as it relates to the need for expedited therapy for the partners of patients with a sexually transmitted disease. Virtual Mentor. 2005;7(10):693-696. doi: 10.1001/virtualmentor.2005.7.10.pfor1-0510.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940.
Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933.
Case and Commentary Nov 2008 Ethics of Expedited Partner Therapy, Commentary 1 Matthew R. Golden, MD, MPH and Matthew Hogben, PhD Using expedited partner therapy to treat certain STDs entails clinical and ethical risks and benefits. Virtual Mentor. 2008;10(11):708-715. doi: 10.1001/virtualmentor.2008.10.11.ccas3-0811.
Case and Commentary Nov 2008 Ethics of Expedited Partner Therapy, Commentary 2 Mark A. Levine, MD Using expedited partner therapy to treat certain STDs entails clinical and ethical risks and benefits. Virtual Mentor. 2008;10(11):708-718. doi: 10.1001/virtualmentor.2008.10.11.ccas3-0811.
Policy Forum Oct 2005 From Research to Policy: Expedited Partner Therapy for Chlamydia Jeffrey D. Klausner, MD, MPH Research is critical to the development of public policy as it relates to the need for expedited therapy for the partners of patients with a sexually transmitted disease. Virtual Mentor. 2005;7(10):693-696. doi: 10.1001/virtualmentor.2005.7.10.pfor1-0510.